{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:02:46Z","timestamp":1791129766277,"version":"4.1.0"},"reference-count":36,"publisher":"BMJ","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1994,7]]},"abstract":"<jats:p>The extent of the acute phase response and the relation between acute phase proteins and cytokines in plasma was investigated in 50 patients with fulminant hepatic failure. On admission, C reactive protein was significantly higher in fulminant hepatic failure (median: 12.4 micrograms\/ml, range:0.2-112 micrograms\/ml) than in 20 controls (median: 0.8 microgram\/ml, range: 0.3-2.9 micrograms\/ml, p &lt; 0.001). Serial measurements showed that plasma C reactive protein increased daily after admission until day 5, the end of the study period. alpha 1-Antitrypsin (AAT) (median: 69.1%, range: 27.5-124%) and fibrinogen (median: 1.10 g\/l, range: 0-2.82 g\/l) were significantly lower in fulminant hepatic failure on admission than in controls (AAT: median: 126%, range: 75.4-149%; fibrinogen: median 2.48 g\/l, range: 1.82-3.39 g\/l, p &lt; 0.001) and did not change subsequently. Both AAT and fibrinogen were maintained at significantly higher concentrations in survivors than in those who did not. Bacterial infection occurred in 23 patients during the course of fulminant hepatic failure, but did not influence the concentrations of these three proteins. Interleukin 6 was significantly higher in fulminant hepatic failure (median: 21.2 pg\/ml, range: 0-871 pg\/ml) than in controls (median: 2.4 pg\/ml, range: 1.5-8.2 pg\/ml, p &lt; 0.001). There was a significant correlation between interleukin 6 and the C reactive protein concentrations in patients with viral hepatitis on admission and in all patients 48 hours later, consistent with other evidence that interleukin 6 stimulates synthesis of this acute phase protein.<\/jats:p>","DOI":"10.1136\/gut.35.7.982","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"982-986","source":"Crossref","is-referenced-by-count":52,"title":["Extent of the acute phase response in fulminant hepatic failure."],"prefix":"10.1136","volume":"35","author":[{"given":"S","family":"Izumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R D","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Pernambuco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1994,7,1]]},"reference":[{"key":"ref_1","first-page":"899","article-title":"Acute phase proteins","volume":"16","author":"Whicher, J.T.; Evans, S.W.","year":"1990","unstructured":"Whicher JT, Evans SW. Acute phase proteins. Hospital Update 1990; 16: 899-905.","journal-title":"Hospital Update"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0171-2985(11)80193-2","article-title":"A review on the biological properties of C-reactive protein","volume":"183","author":"Kolb-Bachofen, V.","year":"1991","unstructured":"Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology 1991; 183: 133-45.","journal-title":"Immunobiology"},{"key":"ref_3","first-page":"349","article-title":"Neutral proteases of human granulocytes (III). Interaction between human granulocyte elastase and plasma protease inhibitors","volume":"34","author":"Ohlsson, K.; Olsson, I.","year":"1974","unstructured":"Ohlsson K, Olsson I. Neutral proteases of human granulocytes (III). Interaction between human granulocyte elastase and plasma protease inhibitors. Scand 7 Clin Lab Invest 1974; 34: 349-55."},{"issue":"19","key":"ref_4","first-page":"109","article-title":"Behaviour of antithrombin III in liver disease","volume":"8","author":"Duckert, F.","year":"1973","unstructured":"Duckert F. Behaviour of antithrombin III in liver disease. ScandJ Gastroenterol 1973; 8 (suppl 19): 109-12.","journal-title":"ScandJ Gastroenterol"},{"key":"ref_5","first-page":"268","article-title":"The effect of fulminant hepatic failure on protein C antigen and activity","volume":"53","author":"Langley, P.G.; Williams, R.","year":"1985","unstructured":"Langley PG, Williams R. The effect of fulminant hepatic failure on protein C antigen and activity. Thromb Haemost 1985; 53: 268-72.","journal-title":"Thromb Haemost"},{"key":"ref_6","first-page":"243","article-title":"Physiological inhibitors of coagulation in fulminant hepatic failure. Blood Coagul Fibrinolysis","volume":"3","author":"Langley, P.G.; Williams, R.","year":"1992","unstructured":"Langley PG, Williams R. Physiological inhibitors of coagulation in fulminant hepatic failure. Blood Coagul Fibrinolysis 1992; 3: 243-7."},{"issue":"200","key":"ref_7","first-page":"211","article-title":"Increased elastase-,-antitrypsin complex in fulminant hepatic failure: relationship to bacterial infection and activation of coagulation","volume":"1991","author":"Langley, P.G.; Hughes, R.D.; Rolando, N.; Williams, R.","unstructured":"Langley PG, Hughes RD, Rolando N, Williams R. Increased elastase-,-antitrypsin complex in fulminant hepatic failure: relationship to bacterial infection and activation of coagulation. Clin ChimActa 1991;-200: 211-20.","journal-title":"Clin ChimActa"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-291X(89)91563-5","article-title":"Changes in rat liver mRNA for cs-1-acid-glycoprotein, apolipoprotein E, apolipoprotein B and beta-actin after mouse recombinant tumor necrosis factor injection","volume":"161","author":"Delers, F.; Mangeney, M.; Raffa, D.","year":"1989","unstructured":"Delers F, Mangeney M, Raffa D, et al. Changes in rat liver mRNA for cs-1-acid-glycoprotein, apolipoprotein E, apolipoprotein B and beta-actin after mouse recombinant tumor necrosis factor injection. Biochem Biophys Res Commun 1989; 161: 81-8.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1084\/jem.162.3.930","article-title":"Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin-1","volume":"162","author":"Ramadori, G.; Sipe, J.D.; Dinarello, C.A.; Mizel, S.B.; Colten, H.R.","year":"1985","unstructured":"Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin-1. JExp Med 1985; 162: 930-42.","journal-title":"JExp Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/eji.1830190821","article-title":"Fate and biological action of human recombinant interleukin-1 in the rat in vivo","volume":"19","author":"Klapproth, J.; Castell, J.V.; Geiger, T.; Andus, T.; Heinrich, P.C.","year":"1989","unstructured":"Klapproth J, Castell JV, Geiger T, Andus T, Heinrich PC. Fate and biological action of human recombinant interleukin-1 in the rat in vivo. Eur J Immunol 1989; 19: 1485-90.","journal-title":"Eur J Immunol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/eji.1830180510","article-title":"Induction of rat acute-phase proteins by interleukin-6 in vivo","volume":"18","author":"Geiger, T.; Andus, T.; Klapproth, J.; Hirano, T.; Kishimoto, T.; Heinrich, P.C.","year":"1988","unstructured":"Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. Induction of rat acute-phase proteins by interleukin-6 in vivo. Eur J Immunol 1988; 18: 717-21.","journal-title":"Eur J Immunol"},{"key":"ref_12","first-page":"1259","article-title":"Interleukin-6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse: comparison with interleukin-1l and tumor necrosis factor","volume":"18","author":"Ramadori, G.; Van Damme, J.; Rieder, H.; Meyer zum Buschenfelde, K.H.","year":"1988","unstructured":"Ramadori G, Van Damme J, Rieder H, Meyer zum Buschenfelde KH. Interleukin-6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse: comparison with interleukin-1l and tumor necrosis factor a. Eur J Immunol 1988; 18: 1259-64."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4049\/jimmunol.142.3.808","article-title":"IL-6 modulates the synthesis of a specific set of acute phase hepatic proteins in vivo","volume":"142","author":"Marinkovic, S.; Jahreis, G.P.; Wong, G.G.; Baumann, H.","year":"1989","unstructured":"Marinkovic S, Jahreis GP, Wong GG, Baumann H. IL-6 modulates the synthesis of a specific set of acute phase hepatic proteins in vivo. J Immunol 1989; 142: 808-12.","journal-title":"J Immunol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0014-5793(88)80766-X","article-title":"Recombinant human interleukin-6 (IL-6\/BSF-2\/HSF) regulates the synthesis of acute phase proteins in human hepatocytes","volume":"232","author":"Castell, J.V.; Gomez-Lechon, M.J.; David, M.; Hirano, T.; Kishimoto, T.; Heinrich, P.C.","year":"1988","unstructured":"Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6\/BSF-2\/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988; 232: 347-50.","journal-title":"FEBS Lett"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","article-title":"Interleukin6 is the major regulator of acute phase protein synthesis in adult human hepatocytes","volume":"242","author":"Castell, J.V.; Gomez-Lechon, M.J.; David, M.","year":"1989","unstructured":"Castell JV, Gomez-Lechon MJ, David M, et al. Interleukin6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letu 1989; 242: 237-9.","journal-title":"FEBS Letu"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.1840120517","article-title":"Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6","volume":"12","author":"Castell, J.V.; Gomez-Lechon, M.J.; David, M.; Fabra, R.; Trullenque, R.; Heinrich, P.C.","year":"1990","unstructured":"Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-86.","journal-title":"Hepatology"},{"key":"ref_17","first-page":"939","article-title":"Highly elevated plasma cytokines in fulminant hepatic failure: correlations with multiorgan failure and death","volume":"12","author":"Sheron, N.; Goka, J.; Wendon, J.","year":"1990","unstructured":"Sheron N, Goka J, Wendon J, et al. Highly elevated plasma cytokines in fulminant hepatic failure: correlations with multiorgan failure and death. Hepatology 1990; 12: 939.","journal-title":"Hepatology"},{"key":"ref_18","first-page":"233","article-title":"Elevated interleukin-6 levels in sera of patients with fulminant hepatitis","volume":"26","author":"Shiratori, Y.; Moriwaki, H.; Kawashima, Y.","year":"1991","unstructured":"Shiratori Y, Moriwaki H, Kawashima Y, et al. Elevated interleukin-6 levels in sera of patients with fulminant hepatitis. GastroenterolJpn 1991; 26: 233.","journal-title":"GastroenterolJpn"},{"key":"ref_19","first-page":"72","article-title":"Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure","volume":"ii:","author":"Muto, Y.; Nouri-Aria, K.; Meager, A.; Alexander, G.J.M.; Eddleston, A.L.W.F.; Williams, R.","year":"1988","unstructured":"Muto Y, Nouri-Aria K, Meager A, Alexander GJM, Eddleston ALWF, Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; ii: 72-4.","journal-title":"Lancet"},{"key":"ref_20","first-page":"282","article-title":"The management of fulminant hepatic failure","volume-title":"Progress in liver disease. Vol 3","author":"Trey, C.; Davidson, C.S.","year":"1970","unstructured":"Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver disease. Vol 3. New York: Grune & Stratton, 1970: 282-98."},{"key":"ref_21","first-page":"430","article-title":"Early indicators of prognosis in fulminant hepatic failure","volume":"97","author":"O'Grady, J.G.; Alexander, G.J.M.; Hayllar, K.M.; Williams, R.","year":"1989","unstructured":"O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterlogy 1989; 97: 430-45.","journal-title":"Gastroenterlogy"},{"key":"ref_22","first-page":"186","article-title":"A solid phase enzyme immunoassay for C-reactive protein: Clinical value and the effect of rheumatoid factor","volume":"68","author":"Highton, J.; Hessian, P.","year":"1984","unstructured":"Highton J, Hessian P. A solid phase enzyme immunoassay for C-reactive protein: Clinical value and the effect of rheumatoid factor. Jf Immunol Methods 1984; 68: 186-92.","journal-title":"Jf Immunol Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","article-title":"Gerinnungsphysiologisches schnellmethode zur bestinnung des fibrinogens","volume":"17","author":"Clauss, A.","year":"1957","unstructured":"Clauss A. Gerinnungsphysiologisches schnellmethode zur bestinnung des fibrinogens. Acta Haematol 1957; 17: 237-46.","journal-title":"Acta Haematol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0076-6879(88)63037-0","article-title":"The acute phase response: an overview","volume":"163","author":"Kushner, I.","year":"1988","unstructured":"Kushner I. The acute phase response: an overview. Methods Enzymol 1988; 163: 373-83.","journal-title":"Methods Enzymol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.1840110110","article-title":"Bacterial infection in acute liver failure","volume":"11","author":"Rolando, N.; Harvey, F.; Brahm, J.","year":"1990","unstructured":"Rolando N, Harvey F, Brahm J, et al. Bacterial infection in acute liver failure. Hepatology 1990; 11: 49-53.","journal-title":"Hepatology"},{"key":"ref_26","first-page":"43","article-title":"Bacterial endotoxin: cytokine mediators and new therapies for sepsis","author":"Dofferhoff, A.S.M.; Bom, V.J.J.; van Ingen, J.","year":"1991","unstructured":"Dofferhoff ASM, Bom VJJ, van Ingen J, et al. Bacterial endotoxin: cytokine mediators and new therapies for sepsis. New York: Wiley-Liss, 1991: 43-54."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/cs0680701","article-title":"Fibrinogen derivatives and platelet activation products in acute and chronic liver disease","volume":"68","author":"Hughes, R.D.; Lane, D.A.; Ireland, H.; Langley, P.G.; Gimson, A.E.S.; Williams, R.","year":"1985","unstructured":"Hughes RD, Lane DA, Ireland H, Langley PG, Gimson AES, Williams R. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. Clin Sci 1985; 68: 701-7.","journal-title":"Clin Sci"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2362.1990.tb01911.x","article-title":"Thrombin-antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome","volume":"20","author":"Langley, P.G.; Forbes, A.F.; Hughes, R.D.; Williams, R.","year":"1990","unstructured":"Langley PG, Forbes AF, Hughes RD, Williams R. Thrombin-antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome. EurJ Clin Invest 1990; 20: 627-31.","journal-title":"EurJ Clin Invest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.142.1.144","article-title":"Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells","volume":"42","author":"Jirik, F.R.; Podor, T.J.; Hirano, T.","year":"1989","unstructured":"Jirik FR, Podor TJ, Hirano T, et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. Jf Immunol 1989; 42: 144-7.","journal-title":"Jf Immunol"},{"key":"ref_30","first-page":"23","article-title":"and the Swiss Dutch J5 Immunoglobulin Study Group. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines","volume":"91","author":"Calandra, T.; Gerain, J.; Heumann, D.; Baumgartner, J.P.; Glauser, M.P.","year":"1991","unstructured":"Calandra T, Gerain J, Heumann D, Baumgartner JP, Glauser MP, and the Swiss Dutch J5 Immunoglobulin Study Group. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. AmJMed 1991; 91: 23-9."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1432-1033.1988.tb14384.x","article-title":"Plasma clearance, organ distribution and target cells of interleukin-6\/hepatocyte stimulating factor in the rat","volume":"177","author":"Castell, J.V.; Geiger, T.; Gross, V.","year":"1988","unstructured":"Castell JV, Geiger T, Gross V, et al. Plasma clearance, organ distribution and target cells of interleukin-6\/hepatocyte stimulating factor in the rat. Eur J Biochem 1988; 177: 357-61.","journal-title":"Eur J Biochem"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/1043-4666(92)90070-8","article-title":"Circulating interleukin 6 as a useful marker for predicting postoperative complications","volume":"4","author":"Oka, Y.; Murata, A.; Nishijima, J.","year":"1992","unstructured":"Oka Y, Murata A, Nishijima J, et al. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992; 4: 298-304.","journal-title":"Cytokine"},{"key":"ref_33","first-page":"201","article-title":"Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery","volume":"111","author":"Ohzato, H.; Yoshizaki, K.; Nishimoto, N.","year":"1992","unstructured":"Ohzato H, Yoshizaki K, Nishimoto N, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111: 201-9.","journal-title":"Surgery"},{"key":"ref_34","first-page":"314","article-title":"Interleukin-6 (IL6) in serum and urine of renal transplant recipients. Clin Exp Immunol","volume":"71","author":"MHJ, Van Qers; der Heyden AAPAM, Van; LA, Aarden","year":"1988","unstructured":"Van Qers MHJ, Van der Heyden AAPAM, Aarden LA. Interleukin-6 (IL6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988; 71: 314-9."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/gut.34.1.41","article-title":"Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis","volume":"34","author":"Heath, D.I.; Cruickshank, A.; Gudgeon, M.; Jehanli, A.; Shenkin, A.; Imrie, C.W.","year":"1993","unstructured":"Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-5.","journal-title":"Gut"},{"key":"ref_36","first-page":"2321","article-title":"Endotoxemia elicits increased circulating bl1-IFN\/IL-6 in man","volume":"142","author":"Fong, Y.; LI1, Moldawer; Marano, M.","year":"1989","unstructured":"Fong Y, Moldawer LI1, Marano M, et al. Endotoxemia elicits increased circulating bl1-IFN\/IL-6 in man. Jlmmunol 1989; 142: 2321-4.","journal-title":"Jlmmunol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.35.7.982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:14:47Z","timestamp":1765602887000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.35.7.982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[1994,7,1]]},"published-print":{"date-parts":[[1994,7]]}},"alternative-id":["10.1136\/gut.35.7.982"],"URL":"https:\/\/doi.org\/10.1136\/gut.35.7.982","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}